Search for: "CIPLA"
Results 161 - 180
of 202
Sorted by Relevance
|
Sort by Date
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin (Repaglinide) – US:… [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist' defense to Walker… [read post]
1 Apr 2010, 3:04 am
., LLC et al v Heritage Pharmaceuticals Inc (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement suit in S D Indiana against Hospira following Para IV challenge (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for patent infringement on Sorafenib (Generic Pharmaceuticals) Viagra (Sildenafil) – Brazil: Patent protection in Brazil: is this the end for Viagra? [read post]
9 Dec 2009, 3:59 pm
: Roche v Cipla (Spicy IP) India, intellectual property and biotechnology industry – to protect, or not to protect (Biotech Blog) Italy: SPCs, competition and refusal to supply – Italian Competition Authority’s responses to ‘refusal to deal’ questionnaire (The SPC Blog) US: Ariad v Lilly – amicus briefs by Regents of University of California et al and various companies (Patent Docs) (Patent Docs) US: Ariad v Lilly – A look back at the roots of the… [read post]
13 May 2010, 4:58 pm
(Patent Docs) Valcyte (Valganciclovir) - India overturns patent on AIDS patient drug (IP Watch) Viread (Tenofovir) - India: Cipla serves legal notice on GWU; demands a written apology for events in relation to the GWU-CII Summit (Spicy IP) Zetia (Ezetimibe) – US: Three claims of Schering's Zetia patent found invalid(Patent Docs) [read post]
12 Mar 2014, 12:58 pm
Judge Michel was the CIPLA’s keynote speaker. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
18 Mar 2010, 2:30 am
Cipla Ltd & Others (Spicy IP) Indian civil society raises concerns over US industry-sponsored IP summits (IP Watch) India: Making Patents Work – Feroz Ali (Spicy IP) India: AIDS patients protest EU-India trade agreement (IP Watch) India: Trade secrets and biotechnology – Lecture V notes (SiNApSE) Mexico: Mexican Supreme Court confirms linkage is available for all product patents, including formulation patents (Olivares & CIA) Poland: No hidden advertising of… [read post]
27 Feb 2009, 5:00 am
(Patent Docs) Lexapro (Escitalopram) – US: Supreme Court refuses to hear appeal from Forest Lab’s allowing Caraco to continue bid to invalidate Lexapro patent despite Forest’s earlier covenant to sue (Law360) (Hal Wegner) Lotrel (Amlodipine) – US: Par and Novartis settle Lotrel lawsuit (Patent Docs) (GenericsWeb) Lovenox (Enoxaparin) – US: Amphastar antitrust claims nixed in Lovenox suit against Sanofi-Aventis (Law360) Opana (Oxymorphone)… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and… [read post]
1 Jun 2010, 8:16 am
Ivax and Cipla, sustained trial decision in favor of Forest and Lundbeck to prote [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
18 Jul 2008, 8:34 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
8 May 2020, 11:00 am
Cipla Ltd., 681 F.3d 1283, 1294 (Fed. [read post]
28 Mar 2023, 9:44 am
Entering into contracts with the two FDA approved generic suppliers, Sandoz and Eugia Pharma, as well as any other manufacturers that are already selling generic versions of enzalutamide in countries where there are currently no patents (such as CIPLA, Glenmark, Dr. [read post]
24 Dec 2014, 9:50 am
Judge Michel was the CIPLA’s keynote speaker. [read post]
17 Jan 2008, 10:00 pm
.'s patent for popular acne medication in hopes of launching a generic version of the drug: (SmartBrief), (IP Law360),Sustiva (Efavirenz) - Grant of licences to produce generics fail to bring price of key HIV drug down in South Africa: (Afro-IP),Tarceva (Erlotinib) - Cipla going ahead with launch of generic despite Natco's failed pre-grant opposition to Roche's Indian patent: (Generic Pharmaceuticals & IP),Tarceva… [read post]
